Sign up to save your podcasts
Or
Share Recap: BIO Stakeholder Briefing on the Medicare Part B Drug Payment Model
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Recap: BIO Stakeholder Briefing on the Medicare Part B Drug Payment Model
On March 8, 2016, the Centers for Medicare and Medicaid Services’ (CMS) Center for Medicare and Medicaid Innovation (CMMI) published a Proposed Rule to test alternative payment models for the reimbursement of drugs covered under Medicare Part B. In the Proposed Rule, CMS has proposed a five-year demonstration program with two phases that will be established sequentially, and intends to require almost all Part B prescribers to participate. Phase I is proposed to begin as Read More
View all episodes
On March 8, 2016, the Centers for Medicare and Medicaid Services’ (CMS) Center for Medicare and Medicaid Innovation (CMMI) published a Proposed Rule to test alternative payment models for the reimbursement of drugs covered under Medicare Part B. In the Proposed Rule, CMS has proposed a five-year demonstration program with two phases that will be established sequentially, and intends to require almost all Part B prescribers to participate. Phase I is proposed to begin as Read More